Thomas J. Westrick Sells 2,750 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock

GE HealthCare Technologies Inc. (NASDAQ:GEHC) CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total transaction of $222,145.00. Following the sale, the chief executive officer now owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock traded down $2.21 during trading hours on Wednesday, reaching $79.34. 2,400,886 shares of the company’s stock were exchanged, compared to its average volume of 3,133,280. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.50. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.83. The company’s 50 day moving average is $79.00 and its two-hundred day moving average is $82.61. The company has a market cap of $36.22 billion, a P/E ratio of 23.20, a price-to-earnings-growth ratio of 3.00 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. The business had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The business’s revenue was up .5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.92 EPS. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.27 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be issued a dividend of $0.03 per share. The ex-dividend date is Friday, July 19th. This represents a $0.12 annualized dividend and a yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

Institutional Investors Weigh In On GE HealthCare Technologies

Institutional investors and hedge funds have recently made changes to their positions in the business. Pathway Financial Advisers LLC purchased a new stake in shares of GE HealthCare Technologies in the first quarter valued at about $25,000. Turtle Creek Wealth Advisors LLC purchased a new stake in GE HealthCare Technologies in the 4th quarter valued at approximately $30,000. BNP Paribas acquired a new stake in GE HealthCare Technologies during the 1st quarter valued at $30,000. Sachetta LLC purchased a new position in GE HealthCare Technologies during the fourth quarter worth $31,000. Finally, Rise Advisors LLC raised its holdings in shares of GE HealthCare Technologies by 241.4% in the first quarter. Rise Advisors LLC now owns 338 shares of the company’s stock worth $31,000 after acquiring an additional 239 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Bank of America dropped their price objective on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Stifel Nicolaus started coverage on GE HealthCare Technologies in a research note on Tuesday. They issued a “buy” rating and a $100.00 price target on the stock. Mizuho reduced their price objective on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research report on Wednesday, May 1st. Finally, The Goldman Sachs Group started coverage on GE HealthCare Technologies in a research report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price for the company. Five research analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $94.58.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.